| (210) | Number of the EPO application | 17779588 |
| (220) | Filing date of the EPO application | 2017.04.03 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2021, 2021.11.24 |
| (110) | EPO patent number | 3439658 |
| (21) | Number of the application | e 2019 0203 |
| (71) | Name(s) of applicant(s), code of the country | ChemoCentryx, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | FAN Pingchen, US;
KRASINSKI Antoni, US;
MALI Venkat Reddy, US;
MIAO Shichang, US;
PUNNA Sreenivas, US;
SONG Yang, US;
STELLA Valentino J., US;
ZENG Yibin, US;
ZHANG Penglie, US; |
| (73) | Name(s) of owner(s), code of the country | CHEMOCENTRYX Inc., US; |
| (54) | Title of the invention | SOLUBLE C5AR ANTAGONISTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/451 (2006.01.01); C07D 211/60 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.03.31 |
| (30) | Priority | 201662317721 P, 2016.04.04, US |
| (86) | International application | PCT/US2017/025704, 2017.04.03 |
| (87) | International publication | WO 2017/176620, 2017.10.12 |